PHARMACEUTICAL COMPOSITIONS

1,204,173. Contraceptive compositions. H. SMITH. 11 Sept., 1967, No. 11132/70. Divided out of 1,204,171. Heading A5B. Contraceptive compositions comprise 13- ethyl-17α-chloroethynyl-17#-hydroxygon- 4-en -3-one as anti-fertility agent in association with a pharmaceutically acceptable carrier (a) in a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: HERCHEL SMITH
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:1,204,173. Contraceptive compositions. H. SMITH. 11 Sept., 1967, No. 11132/70. Divided out of 1,204,171. Heading A5B. Contraceptive compositions comprise 13- ethyl-17α-chloroethynyl-17#-hydroxygon- 4-en -3-one as anti-fertility agent in association with a pharmaceutically acceptable carrier (a) in an amount of from 5 to 90 micrograms formulated for daily administration and release in one day or (b) formulated as a delayed release composition for administration less frequently than daily comprising an amount of from 5 to 150 micrograms multiplied by the number of days over which it is to be released. The anti-fertility agent may be present as the racemate or d-enantiomer. The composition may be administered orally, parenterally or rectally in the form of tablets, capsules, powders, dispersible granules, cachets, solutions, suspensions, emulsions, vials, ampoules, suppositories or a delayed release composition, such as an implant, containing a plastic or a modified carboxymethyl-cellulose.